Search results
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman. He was convicted of financial crimes for which he served over six years in federal prison and was fined over 70 million dollars.
May 19, 2022 · Martin Shkreli, a former pharmaceutical executive known for raising the price of a life-saving drug by 5,000%, was released from prison and transferred Wednesday to community confinement, the ...
Jan 14, 2022 · Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a lifesaving drug, a federal judge...
Jan 14, 2022 · Martin Shkreli, the former pharmaceutical executive best known for unapologetically hiking the price of a lifesaving medication, must pay $64.6 million and will be barred for life from the drug...
Mar 9, 2018 · NEW YORK — Martin Shkreli, the smirking “Pharma Bro” vilified for jacking up the price of a lifesaving drug, was sentenced Friday to seven years in prison for defrauding investors in two failed...
Mar 9, 2018 · Shkreli, a Former Hedge Fund Manager and CEO of a Biopharmaceutical Company, Defrauded Investors and Engaged in Stock Fraud Scheme Involving Publicly Traded Retrophin Inc.
May 18, 2022 · Martin Shkreli, the former pharmaceutical executive known for raising the price of a lifesaving drug more than 40-fold, has been released from prison, where he had been serving a seven-year term...
Jan 23, 2024 · A federal appeals court Tuesday upheld a lifetime ban on “pharma bro” Martin Shkreli from working in the pharmaceuticals industry as well as an order to pay up to $64.6 million in disgorged...
May 18, 2022 · Martin Shkreli, a former pharmaceutical investor convicted of securities fraud, has been released from prison after having served part of a seven-year sentence.
Mar 9, 2018 · Martin Shkreli, a former pharmaceutical executive notorious for sharply increasing drug prices, mounting sneering defenses of his actions and even issuing a bounty for one of Hillary Clinton’s...